Red Maple Allergy Shots: Common Tree, Secondary Spring Allergen
Red maple (Acer rubrum) is among the most abundant Eastern US trees by basal area and produces distinctive red flowers in March, making patients over-suspect it. However, its mixed insect-and-wind pollination limits airborne loads relative to wind-pollinated box-elder.
Red Maple Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to red maple — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of red maple allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of red maple immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of red maple extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for red maple allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing red maple extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription red maple immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat red maple allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Red Maple?
The biology, taxonomy, and clinical fingerprint of Red Maple — the foundation of how SCIT targets it.
Red maple is unmistakable in March by its brilliant red flower display before leaves emerge, but mixed insect-and-wind pollination limits airborne pollen load relative to dioecious box-elder.
- Scientific name
- Acer rubrum
- Family
- Sapindaceae (formerly Aceraceae)Soapberry family (maple subfamily)
- Type
- Tree pollen — mixed insect-and-wind pollination; March flower display precedes leaves
- Native to
- Eastern US, especially abundant in mixed hardwood forests, Florida swamps, Appalachian cove forests
- Allergen proteins
- No formally named IUIS allergen for Acer rubrum as of May 2026 (no Ace r allergen at WHO/IUIS)
- Particle size
- 22–51 × 20–36 µm (variable across Acer species)
- Avoidance difficulty
- Moderate
How Red Maple Allergy Presents
Symptoms by body system — useful for distinguishing Red Maple sensitivity from overlapping allergies and infections.
Respiratory
- Rhinitis and sneezing during March–May near dense Eastern red maple stands
- Nasal congestion coinciding with red maple spring flowering in April
- Worsened symptoms typically reflect box-elder or early grass co-sensitization
- Mild asthma exacerbation in patients near dominant red maple canopy habitats
Ocular
- Watery, itchy eyes during the March–May red maple pollen window
- Conjunctival irritation near Appalachian cove forests or Florida swamps in spring
- Contact lens intolerance during spring Sapindaceae pollen season
Dermal
- Atopic dermatitis flares during the spring Acer pollen window
- Contact urticaria from handling red maple foliage in sensitized individuals (rare)
- Periorbital swelling in highly sensitized patients near peak exposure habitats
Systemic
- Mild fatigue during the spring red maple pollen season
- Sleep disruption from nasal congestion in patients with high local exposure
- Generalized malaise in patients co-sensitized to red maple, box-elder, and oak
- Reduced productivity during the overlapping spring pollen window
Red maple is the tree my patients can name — those bright red March flowers are unmistakable. But unless you live under a canopy of them in the Appalachians, your March allergies are more likely box-elder, the maple cousin that actually dumps its pollen into the wind.
When & Where Red Maple Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: March–April across the Eastern US; bright red flowers are the earliest visible spring tree display, appearing before leaf emergence· ~8–10 weeks; red maple is among the earliest flowering Eastern hardwoods, overlapping alder and elm pollen windows
US Exposure Map
10 high-intensity statesWhat Red Maple Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Red maple cross-reactivity is primarily within Acer — high with box-elder but incomplete; limited cross-reactivity with walnut, sycamore, oak, and willow based on Western blot and IgE inhibition data.
Standard combined Sapindaceae prescription covering red maple + box-elder
High but incomplete intra-Acer cross-reactivity; box-elder has unique IgE-binding bands
Is SCIT Right for Your Red Maple Allergy?
Answer five questions to assess whether red maple SCIT is indicated for your spring Eastern US allergy profile.
How severe are your March–May spring allergy symptoms in the Eastern US?
The Red Maple SCIT Protocol
Red maple SCIT uses a non-standardized Acer rubrum extract; in most settings, this is combined with box-elder in the maple-boxelder mix prescription rather than prescribed as a standalone red maple extract.
Starting in fall, the allergist escalates from the most dilute Acer extract to the maintenance dose over 6–8 months. The 30-minute post-injection observation period is mandatory at every visit. Build-up timing ideally targets completion before the March Acer flowering season.
Monthly maintenance injections continue through successive spring seasons. Annual symptom tracking helps assess improvement across the March–May Acer window. The 30-minute observation period is required at each visit.
After completing the recommended course, the allergist reviews symptom scores across two successive spring seasons before recommending discontinuation.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Red Maple SCIT
No SCIT RCT has been published for red maple or any Acer species. Evidence is extrapolated from box-elder/maple asthma-hospitalization data and the AAAAI/ACAAI Practice Parameter.
- Box-elder/maple counts correlate with severe asthma hospitalizations50%Dales et al., Int Arch Allergy Immunol 2008;146:241–247 — box-elder/maple Canadian cities study
- Estimated benefit from non-standardized tree SCIT (extrapolated framework)42%Cox L et al., J Allergy Clin Immunol 2011;127:S1–S55 — Practice Parameter Third Update
Red maple SCIT has no dedicated RCT. Its mixed pollination biology limits clinical relevance to habitats with dense dominant canopy. For most patients with spring Acer sensitization, the maple-boxelder mix — which covers both red maple and the more clinically dominant wind-pollinated box-elder — is the more pragmatic prescription than red maple alone. Curex at-home IgE testing can distinguish red maple from box-elder sensitization, avoiding the assumption that a maple is a maple.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Red Maple SCIT Side Effects
Red maple SCIT side effects are consistent with non-standardized inhalant tree extracts; local reactions are most common and serious systemic events are rare.
Local reactions
4 documentedSystemic reactions
4 documentedSCIT has traditionally been administered in a clinic equipped for emergency treatment; for eligible maintenance patients, Curex makes safe at-home self-administration possible with a personalized serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first dose and every dose change supervised live over Zoom. A 30-minute observation follows every dose and remains a core safety step.
SCIT vs Alternatives for Red Maple
Eastern spring Acer allergy management options span daily medications, avoidance (feasible for some patients not living under dense canopy), sublingual immunotherapy, and SCIT — now available as a weekly at-home shot with Curex.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Limited evidence | Comparable (extrapolated) | Feasible if canopy exposure low | Good short-term control |
| 5-yr cost | $3,500–$9,000 | $39/mo at home | Low | $500–$2,000/yr |
| Duration | 3–5 years | 3–5 years | Ongoing | Lifelong |
| Convenience | Weekly at-home build-up easing to monthly maintenance with Curex | Daily drops at home | Moderate — avoid dense maple areas | Daily pill/spray |
| Safety | Very safe; sterile-compounded serum plus live Zoom supervision of every dose change | Very safe | Excellent | Generally safe |
| Lasting effect | Yes, years post-tx | Yes, years post-tx | No | No |
SCITBest
SLIT
Avoidance
Medications
For confirmed Acer sensitization with multi-season spring symptoms, the maple-boxelder combined SCIT prescription typically provides better coverage than red maple alone — and with Curex, eligible patients self-administer that shot at home for $129/month instead of attending clinic visits, with the first dose and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand.
What Red Maple SCIT Actually Costs
Most major US insurers cover red maple SCIT under standard allergy benefits when ordered by a board-certified allergist with documented positive Acer sensitization; the clinical rationale for red maple vs the combined maple-boxelder prescription should be documented for prior authorization purposes.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your red maple allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Red Maple SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Red maple is among the most abundant Eastern US trees by basal area — it dominates vast areas of the Appalachians, New England, and the Southeast — but tree abundance does not directly translate to aeroallergen importance. The key factor is pollination biology: red maple uses mixed insect-and-wind pollination, meaning a substantial fraction of its pollen is transferred by insects (bees, flies) directly from flower to flower rather than released into the air. This substantially reduces airborne pollen concentrations compared to fully wind-pollinated trees like box-elder (A. negundo) or cottonwood (Populus). In habitats where red maple is the absolutely dominant canopy tree — dense Appalachian cove forests, Florida cypress-swamp edges, or mass urban stormwater plantings — the aerial pollen load can be clinically significant. In most suburban and urban settings, box-elder is the more important Acer allergen.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.